Pitfalls in lymphoma pathology: avoiding errors in diagnosis of lymphoid tissues
暂无分享,去创建一个
[1] F. Mayall,et al. A review of 50 consecutive cytology cell block preparations in a large general hospital. , 1997, Journal of clinical pathology.
[2] S. Banerjee,et al. Audit of tumour histopathology reviewed by a regional oncology centre. , 1995, Journal of clinical pathology.
[3] Juan F. García,et al. Intrafollicular neoplasia/in situ follicular lymphoma: review of a series of 13 cases , 2010, Histopathology.
[4] K. Amara,et al. Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] J. Lester,et al. The clinical impact of expert pathological review on lymphoma management: a regional experience , 2003, British journal of haematology.
[6] L. Medeiros,et al. B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma , 2013 .
[7] P. Went,et al. Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores , 2010, Leukemia & lymphoma.
[8] X. Zhao. Pitfalls in diagnostic hematopathology: part I. , 2009, International journal of clinical and experimental pathology.
[9] Matija Snuderl,et al. B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma , 2010, The American journal of surgical pathology.
[10] A. Bagg,et al. B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma , 2012 .
[11] J. Chi,et al. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma , 2008, Journal of cellular and molecular medicine.
[12] S. Swerdlow,et al. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma. , 2006, Human pathology.
[13] B. Bain,et al. Best Practice in Lymphoma Diagnosis and Reporting , 2012 .
[14] G. Aralica,et al. The accuracy of fine needle aspiration cytology and flow cytometry in evaluation of nodal and extranodal sites in patients with suspicion of lymphoma. , 2010, Collegium antropologicum.
[15] D. Poller,et al. Referrals for second opinion in surgical pathology: implications for management of cancer patients in the UK. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[16] D. Howlett,et al. Diagnostic adequacy and accuracy of fine needle aspiration cytology in neck lump assessment: results from a regional cancer network over a one year period. , 2007, The Journal of laryngology and otology.
[17] A. LaCasce,et al. Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] W. Chan,et al. Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma , 2005, Modern Pathology.
[19] S. Serrano,et al. FISH is better than BIOMED-2 PCR to detect IgH/BCL2 translocation in follicular lymphoma at diagnosis using paraffin-embedded tissue sections. , 2008, Leukemia research.
[20] A. Carbone,et al. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. , 2010, Human pathology.
[21] M Hummel,et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.
[22] L. Staudt,et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.
[23] E. Montserrat,et al. Chronic lymphocytic leukaemia/small lymphocytic leukaemia. , 2001 .
[24] P. Isaacson. Haematopathology practice: the commonest problems encountered in a consultation practice , 2007, Histopathology.
[25] W. Chan,et al. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. , 1995, Blood.
[26] L. Bereczki,et al. Optimization of PCR amplification for B-and T-cell clonality analysis on formalin-fixed and paraffin-embedded samples , 2008, Pathology & Oncology Research.
[27] X. Zhao. Pitfalls in diagnostic hematopathology -- Part II. , 2009, International journal of clinical and experimental pathology.
[28] Kai Fu,et al. A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy , 2009, Clinical Cancer Research.
[29] N. Aluwihare,et al. The role of freehand needle core biopsy in the diagnosis of isolated axillary lymphadenopathy. , 2009, Breast.
[30] D. Gonzalez,et al. Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkin’s lymphomas with high rates of somatic hypermutation , 2006, Journal of Clinical Pathology.
[31] J. Raemaekers,et al. The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma. , 2007, Haematologica.
[32] Y. Kwong,et al. Common misdiagnoses in lymphomas and avoidance strategies. , 2010, The Lancet. Oncology.
[33] S. Richards,et al. The development of integrated haematopathology laboratories: a new approach to the diagnosis of leukaemia and lymphoma. , 2003, Clinical and laboratory haematology.
[34] K. Imrie,et al. In situ localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical BCL-2/IGH fusion gene in blood and lymph node , 2009, Leukemia.
[35] R. Siebert,et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. , 2006, The Journal of molecular diagnostics : JMD.
[36] T. Golub,et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. , 2004, Blood.
[37] B. Coiffier,et al. Nodular, lymphocyte‐predominant Hodgkin lymphoma , 2010, Cancer.